ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
暂无分享,去创建一个
Cyrus Chargari | A. Félix | C. Centeno | F. Joly | D. Cibula | I. Zapardiel | M. Raspollini | D. Querleu | P. Mathevet | F. Peccatori | R. Nout | J. Persson | M. Schmid | A. Oaknin | D. Fischerová | D. Lorusso | U. Mahantshetty | S. Lax | K. Tamussino | R. Naik | J. Lindegaard | A. Stepanyan | F. Planchamp | C. Kohler | Daniela Jahnn-Kuch | S.R. Bernabé | V. Svintsitskyi
[1] H. Woopen,et al. GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee. , 2022, Cancer treatment reviews.
[2] Juan Zhou,et al. Local treatment improves survival in patients with stage IVB cervical cancer. , 2022, Gynecologic oncology.
[3] Sudeep Gupta,et al. Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future , 2022, International Journal of Gynecological Cancer.
[4] Yi Huang,et al. Therapeutic strategy analysis of patients with advanced stage high‐grade neuroendocrine cervical cancer: A real‐world multicenter study , 2022, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[5] C. Kirisits,et al. Prognostic implications of uterine cervical cancer regression during chemoradiation evaluated by the T-score in the multicenter XXX study. , 2022, International journal of radiation oncology, biology, physics.
[6] Jeong-Won Lee,et al. Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers , 2021, Cancer research and treatment.
[7] L. Stalpers,et al. Primary or adjuvant chemoradiotherapy for cervical cancer with intraoperative lymph node metastasis - A review. , 2021, Cancer treatment reviews.
[8] Longyun Chen,et al. PD-L1, Mismatch Repair Protein, and NTRK Immunohistochemical Expression in Cervical Small Cell Neuroendocrine Carcinoma , 2021, Frontiers in Oncology.
[9] F. Landoni,et al. The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer. , 2021, European journal of cancer.
[10] D. Aoki,et al. Cancer of the cervix uteri: 2021 update , 2021, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[11] P. Morice,et al. Long-term oncological safety of sentinel lymph node biopsy in early-stage cervical cancer: A post-hoc analysis of SENTICOL I and SENTICOL II cohorts. , 2021, Gynecologic oncology.
[12] J. Overgaard,et al. Hypoxic gene expression is a prognostic factor for disease free survival in a cohort of locally advanced squamous cell cancer of the uterine cervix , 2021, Acta oncologica.
[13] A. Gavin,et al. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers , 2021, European journal of cancer.
[14] F. Heredia,et al. Conization and lymph node evaluation in low-risk cervical cancer. Is it time to avoid radical surgery? Retrospective series and literature review. , 2021, European journal of obstetrics, gynecology, and reproductive biology.
[15] K. Hua,et al. Identification of a novel six‐gene signature with potential prognostic and therapeutic value in cervical cancer , 2021, Cancer medicine.
[16] P. T. Jensen,et al. From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups? , 2021, Gynecologic oncology.
[17] C. Della Rocca,et al. Radical Surgery After Neoadjuvant Chemotherapy for Locally Advanced Neuroendocrine Cancer of the Cervix , 2021, AntiCancer Research.
[18] E. Bruera,et al. Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update , 2021, Supportive Care in Cancer.
[19] A. Martin Martinez,et al. Post-Conization FIGO stage IA1 squamous cell cervical carcinoma; is hysterectomy necessary? , 2021, European journal of obstetrics, gynecology, and reproductive biology.
[20] J. Teixeira,et al. Conservative treatment of microinvasive squamous cell carcinoma of the cervix stage IA1: Defining conization height to an optimal oncological outcome , 2021, PloS one.
[21] Jian Chen,et al. Prognostic factors and treatment of neuroendocrine tumors of the uterine cervix based on the FIGO 2018 staging system: a single-institution study of 172 patients , 2021, PeerJ.
[22] A. Yapar,et al. Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy , 2021, Journal of gynecologic oncology.
[23] G. Scambia,et al. The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients. , 2021, Gynecologic oncology.
[24] F. Strasser,et al. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆ , 2021, ESMO open.
[25] M. Kamdar,et al. Essential Package of Palliative Care for Women With Cervical Cancer: Responding to the Suffering of a Highly Vulnerable Population , 2021, JCO global oncology.
[26] T. Ind. Overview of fertility sparing treatments for cervical cancer. , 2021, Best practice & research. Clinical obstetrics & gynaecology.
[27] A. Sundin,et al. Interobserver agreement of transvaginal ultrasound and magnetic resonance imaging in local staging of cervical cancer , 2021, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[28] F. Amant,et al. Fertility sparing treatment in cervical cancer management in pregnancy. , 2021, Best practice & research. Clinical obstetrics & gynaecology.
[29] E. Sala,et al. Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018 , 2021, European Radiology.
[30] M. Washington,et al. The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer , 2021, CA: a cancer journal for clinicians.
[31] S. Scasso,et al. Neoadjuvant chemotherapy in pregnant patients with cervical cancer: a Latin-American multicenter study , 2021, International Journal of Gynecological Cancer.
[32] A. Nica,et al. Cervical conization and lymph node assessment for early stage low-risk cervical cancer , 2021, International Journal of Gynecological Cancer.
[33] F. Landoni,et al. Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer , 2021, International Journal of Gynecological Cancer.
[34] Tsuyoshi Saito,et al. The validity of the subsequent pregnancy index score for fertility-sparing trachelectomy in early-stage cervical cancer. , 2021, Fertility and sterility.
[35] C. Faloppa,et al. Predictive Factors for Residual Disease After Conization in Cervical Cancer , 2021, Annals of Surgical Oncology.
[36] Young Seok Kim,et al. Optimal treatment strategies for small cell carcinoma of the uterine cervix: A retrospective multi-center study (KROG 19-03). , 2021, European journal of obstetrics, gynecology, and reproductive biology.
[37] N. Buza. HER2 Testing and Reporting in Endometrial Serous Carcinoma: Practical Recommendations for HER2 Immunohistochemistry and Fluorescent In Situ Hybridization: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting. , 2021, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[38] Hui Wang,et al. Medical Management of Inoperable Malignant Bowel Obstruction , 2020, The Annals of pharmacotherapy.
[39] P. Dundr,et al. Tumour-free distance: a novel prognostic marker in patients with early-stage cervical cancer treated by primary surgery , 2020, British Journal of Cancer.
[40] K. Hua,et al. Management of Cervical Cancer in Pregnant Women: A Multi-Center Retrospective Study in China , 2020, Frontiers in Medicine.
[41] Y. Shibamoto,et al. The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments , 2020, BMC Cancer.
[42] Manjulika Das. WHO launches strategy to accelerate elimination of cervical cancer. , 2020, The Lancet. Oncology.
[43] Huanwen Wu,et al. Oncologic and obstetric outcomes after conization for adenocarcinoma in situ or stage IA1 cervical cancer , 2020, Scientific Reports.
[44] M. Koual,et al. Does a pre-operative conization improve disease-free survival in early-stage cervical cancer? , 2020, Archives of Gynecology and Obstetrics.
[45] J. Meuwly,et al. Survival of the fetus: cervical cancer and pregnancy, a challenging combination , 2020, The Lancet.
[46] C. Kirisits,et al. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study. , 2020, Gynecologic oncology.
[47] J. Fujimoto,et al. Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix , 2020, International Journal of Gynecological Cancer.
[48] L. Mileshkin,et al. A systematic review of the impact of contemporary treatment modalities for cervical cancer on women’s self-reported health-related quality of life , 2020, Supportive Care in Cancer.
[49] P. A. Futreal,et al. Comparative genomics of high grade neuroendocrine carcinoma of the cervix , 2020, PloS one.
[50] R. Bharathan,et al. Sentinel lymph node biopsy alone in the management of early cervical carcinoma , 2020, International Journal of Gynecological Cancer.
[51] C. Sonetto,et al. Primary conization overcomes the risk of developing local recurrence following laparoscopic radical hysterectomy in early stage cervical cancer , 2020, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[52] M. Plante,et al. Simple vaginal trachelectomy in women with early-stage low-risk cervical cancer who wish to preserve fertility: the new standard of care? , 2020, International Journal of Gynecological Cancer.
[53] Jingxin Cheng,et al. Prognostic Factors and Local Treatment Modalities of Small-Cell Carcinoma of the Cervix: An Analysis According to the International Federation of Gynecology and Obstetrics Stage , 2020, Cancer management and research.
[54] T. Turan,et al. Primary leiomyosarcoma of the uterine cervix: report of 4 cases, systematic review, and meta-analysis , 2020, Tumori.
[55] Scott A Harvey,et al. A fight-and-flight for life: A rare case of advanced cervical cancer in pregnancy , 2020, Gynecologic oncology reports.
[56] Yudong Wang,et al. A case of successful maintained pregnancy after neoadjuvant chemotherapy plus radical surgery for stage IB3 cervical cancer diagnosed at 13 weeks , 2020, BMC Pregnancy and Childbirth.
[57] E. Darai,et al. Invasive and in situ cervical cancer associated with pregnancy: analysis from the French cancer network (CALG: Cancer Associé à La Grossesse) , 2020, Clinical and Translational Oncology.
[58] Jason D. Wright,et al. Prognostic significance of lymphovascular space invasion for stage IA1 and IA2 cervical cancer , 2020, International Journal of Gynecological Cancer.
[59] F. Roila,et al. Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.
[60] C. Bourgioti,et al. Imaging of Gynecologic Malignancy in a Reproductive Age Female: Cancer During Pregnancy. , 2020, Radiologic clinics of North America.
[61] P. Casali,et al. Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU) , 2020, ESMO Open.
[62] A. Mandić,et al. Neoadjuvant chemotherapy in locally advanced cervical cancer in pregnancy-Review of the literature. , 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[63] G. Vorgias,et al. Abdominal radical trachelectomy during pregnancy: A systematic review of the literature. , 2020, Journal of gynecology obstetrics and human reproduction.
[64] M. E. Leão,et al. Evaluation of uterine cervical cancer in pregnancy: A cross-sectional study. , 2020, European journal of obstetrics, gynecology, and reproductive biology.
[65] F. Landoni,et al. European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer , 2020, International Journal of Gynecological Cancer.
[66] Jacques Ferlay,et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis , 2019, The Lancet. Global health.
[67] S. Vesely,et al. Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy. , 2019, Gynecologic oncology.
[68] K. Tanderup,et al. Evaluation of a new prognostic tumor score in locally advanced cervical cancer integrating clinical examination and magnetic resonance imaging. , 2019, International journal of radiation oncology, biology, physics.
[69] Anna Lee,et al. Primary sarcoma of the cervix: an analysis of patient and tumor characteristics, treatment patterns, and outcomes , 2019, Journal of gynecologic oncology.
[70] M. Fumagalli,et al. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[71] A. Giordano,et al. Cervical cancer in pregnancy: Analysis of the literature and innovative approaches , 2019, Journal of cellular physiology.
[72] D. Gaffney,et al. 216 The deleterious survival impact of positive lymph nodes in cervical cancer: implications of the new FIGO staging system , 2019, International Journal of Gynecological Cancer.
[73] S. Podgaec,et al. Consensus for vaginal stenosis prevention in patients submitted to pelvic radiotherapy , 2019, PloS one.
[74] M. Dimopoulos,et al. Taxanes during pregnancy in cervical cancer: A systematic review and pooled analysis. , 2019, Cancer treatment reviews.
[75] Dongcheng Wu,et al. Diagnosis and treatment of cervical cancer in pregnant women , 2019, Cancer medicine.
[76] I. Haldorsen,et al. What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer? , 2019, Current Oncology Reports.
[77] Tsuyoshi Saito,et al. Obstetrical prognosis of patients who underwent vaginal radical trachelectomy during pregnancy , 2019, The journal of obstetrics and gynaecology research.
[78] Liangsheng Fan,et al. Treatment and clinical outcomes of cervical cancer during pregnancy. , 2019, Annals of translational medicine.
[79] J. Ryan,et al. Incidence, management, and sequelae of ureteric obstruction in women with cervical cancer , 2019, Supportive Care in Cancer.
[80] Zheyan Liu,et al. Elevated PD-L1 expression predicts poor survival outcomes in patients with cervical cancer , 2019, Cancer Cell International.
[81] Jia-xin Yang,et al. Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study , 2019, Front. Oncol..
[82] Xiaoxin Ma,et al. Prognostic factors and outcomes of early-stage small cell neuroendocrine carcinoma of the cervix: 37 cases from a single center , 2019, PeerJ.
[83] J. Bento,et al. Surgical Management of Malignant Intestinal Obstruction: Outcome and Prognostic Factors. , 2019, Chirurgia.
[84] J. Berek,et al. Revised FIGO staging for carcinoma of the cervix uteri , 2019, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[85] J. Ordi,et al. HPV-negative tumors of the uterine cervix , 2019, Modern Pathology.
[86] B. van Calster,et al. Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy , 2019, International Journal of Gynecologic Cancer.
[87] G. Eleje,et al. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. , 2019, The Cochrane database of systematic reviews.
[88] L. Lecointre,et al. Type B Laparoscopic Radical Trachelectomy with Uterine Artery Preservation for Stage IB1 Cervical Cancer. , 2019, Journal of minimally invasive gynecology.
[89] P. Ramirez,et al. Conservative management of cervical cancer in pregnancy , 2019, International Journal of Gynecological Cancer.
[90] P. Dundr,et al. A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX) , 2019, International Journal of Gynecologic Cancer.
[91] I. Konishi,et al. Validation of the 2018 FIGO cervical cancer staging system. , 2019, Gynecologic oncology.
[92] C. Gilks,et al. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists , 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[93] M. Dietrich,et al. Development and Validation of the Lymphedema Symptom Intensity and Distress Survey-Lower Limb. , 2018, Lymphatic research and biology.
[94] C. Michener,et al. Radical Trachelectomy for Early Stage Cervical Cancer , 2018, Current Treatment Options in Oncology.
[95] V. Gebski,et al. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer , 2018, The New England journal of medicine.
[96] Y. Huang,et al. Independent risk factors for ovarian metastases in stage IA‐IIB cervical carcinoma , 2018, Acta obstetricia et gynecologica Scandinavica.
[97] G. Scambia,et al. Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery—the “PRICE“ study 2: role of conventional and DW-MRI , 2018, European Radiology.
[98] M. Paschoini,et al. Chemotherapy for cervical cancer in pregnancy , 2018, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[99] L. Denny,et al. FIGO Cancer Report 2018 , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[100] A. Fagotti,et al. Locally advanced cervical cancer complicating pregnancy: A case of competing risks from the Catholic University of the Sacred Heart in Rome. , 2018, Gynecologic oncology.
[101] Kiyoko Kato,et al. Infertility after abdominal trachelectomy , 2018, Acta obstetricia et gynecologica Scandinavica.
[102] C. Bourgioti,et al. Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer During Pregnancy: A Provocative Surgical Approach. Overview of the Literature and a Single-Institute Experience , 2018, International Journal of Gynecologic Cancer.
[103] Chin-Chen Chang,et al. Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients , 2018, European Radiology.
[104] P. Ramirez,et al. Simple trachelectomy with pelvic lymphadenectomy as a viable treatment option in pregnant patients with stage IB1 (≥2 cm) cervical cancer: Bridging the gap to fetal viability. , 2018, Gynecologic oncology.
[105] C. Haie-meder,et al. Multimodal Management of Locally Advanced Neuroendocrine Cervical Carcinoma: A Single Institution Experience , 2018, International Journal of Gynecologic Cancer.
[106] A. Neugut,et al. Trends in Use and Survival Associated With Fertility-Sparing Trachelectomy for Young Women With Early-Stage Cervical Cancer. , 2018, Obstetrics and gynecology.
[107] C. Paul,et al. Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix , 2018, The Australian & New Zealand journal of obstetrics & gynaecology.
[108] Richard Pötter,et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer , 2018, International Journal of Gynecologic Cancer.
[109] C. Tempfer,et al. Neuroendocrine carcinoma of the cervix: a systematic review of the literature , 2018, BMC Cancer.
[110] R. Pötter,et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer , 2018, International Journal of Gynecologic Cancer.
[111] R. Pötter,et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[112] C. Simone,et al. Patterns of Care for Stage IA Cervical Cancer: Use of Definitive Radiation Therapy Versus Hysterectomy , 2018, International Journal of Gynecologic Cancer.
[113] G. Scambia,et al. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery , 2018, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[114] R. Angioli,et al. Assessment of Quality of Life and Urinary and Sexual Function After Radical Hysterectomy in Long-Term Cervical Cancer Survivors , 2018, International Journal of Gynecologic Cancer.
[115] F. Amant,et al. Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study , 2018, European Radiology.
[116] O. Aboumarzouk,et al. Malignant ureteric obstruction decompression: how much gain for how much pain? A narrative review , 2018, Journal of the Royal Society of Medicine.
[117] Kiyoko Kato,et al. Surgical treatment and outcome of early invasive adenocarcinoma of the uterine cervix (FIGO stage IA1) , 2018, Asia-Pacific journal of clinical oncology.
[118] K. Yoshihara,et al. The Safety and Effectiveness of Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer During Pregnancy , 2018, International Journal of Gynecologic Cancer.
[119] E. Miyagi,et al. Radiation Therapy for Patients with Bone Metastasis from Uterine Cervical Cancer: Its Role and Optimal Radiation Regimen for Palliative Care. , 2018, Anticancer research.
[120] H. Chung,et al. Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation , 2018, PloS one.
[121] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[122] T. Turan,et al. Therapy Modalities, Prognostic Factors, and Outcome of the Primary Cervical Carcinosarcoma: Meta-analysis of Extremely Rare Tumor of Cervix , 2017, International Journal of Gynecologic Cancer.
[123] M. Kohler,et al. Why do we continue to overtreat stage Ia carcinoma of the cervix? , 2017, American journal of obstetrics and gynecology.
[124] N. Siddiqui,et al. The Current Burden of Follow-up of Stage 1A1 Cervical Cancer , 2017, Journal of lower genital tract disease.
[125] P. Phillips,et al. Hysterectomy With Radiotherapy or Chemotherapy or Both for Women With Locally Advanced Cervical Cancer , 2017, Clinical nurse specialist CNS.
[126] K. Matsuo,et al. Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer , 2017, American journal of obstetrics and gynecology.
[127] E. Fields,et al. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival. , 2017, Brachytherapy.
[128] K. Matsuo,et al. Significance of uterine corpus tumor invasion in early-stage cervical cancer. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[129] N. Horowitz,et al. Management and outcome of cervical cancer diagnosed in pregnancy , 2017, American journal of obstetrics and gynecology.
[130] A. Gadducci,et al. Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists. , 2017, Gynecologic oncology.
[131] J. Teixeira,et al. Analysis of Conservative Surgical Treatment and Prognosis of Microinvasive Squamous Cell Carcinoma of the Cervix Stage IA1: Results of Follow-Up to 20 Years , 2017, International Journal of Gynecologic Cancer.
[132] X. Fang,et al. Clear Cell Carcinoma of the Uterine Cervix: A Clinical and Pathological Analysis of 47 Patients Without Intrauterine Diethylstilbestrol Exposure , 2017, International Journal of Gynecologic Cancer.
[133] Ying Zhang,et al. Abdominal radical trachelectomy guided by sentinel lymph node biopsy for stage IB1 cervical cancer with tumors >2 cm , 2016, Oncotarget.
[134] Chao Lu,et al. Retrospective study , 2016, Medicine.
[135] A. Fyles,et al. Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update. , 2016, Current oncology.
[136] E. Bruera,et al. Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer. , 2015, Gynecologic oncology.
[137] James Java,et al. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[138] N. deSouza,et al. A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer. , 2015, Cancer treatment reviews.
[139] J. Ordi,et al. HPV‐negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis , 2015, BJOG : an international journal of obstetrics and gynaecology.
[140] J. Coebergh,et al. Second primary cancers in survivors of cervical cancer in The Netherlands: Implications for prevention and surveillance. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[141] P. Jacobsen,et al. Validation of the Distress Thermometer worldwide: state of the science , 2014, Psycho-oncology.
[142] A. Yapar,et al. Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[143] G. Scambia,et al. Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis , 2013, BMC Cancer.
[144] L. Ramondetta. What is the appropriate approach to treating women with incurable cervical cancer? , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.
[145] M. Zikan,et al. Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial. , 2013, Gynecologic oncology.
[146] S. Beriwal,et al. Complete Metabolic Response After Definitive Radiation Therapy for Cervical Cancer: Patterns and Factors Predicting for Recurrence , 2012 .
[147] G. Thomas,et al. Cancer of the cervix uteri , 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[148] G. Kenter,et al. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. , 2012, Gynecologic oncology.
[149] G. Scambia,et al. Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study. , 2012, Gynecologic oncology.
[150] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[151] P. Gehrig,et al. Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document. , 2011, Gynecologic oncology.
[152] O. Abulafia,et al. Hydronephrosis as a Prognostic Indicator of Survival in Advanced Cervix Cancer , 2011, International Journal of Gynecologic Cancer.
[153] B. K. Park,et al. Prognostic significance of MRI-detected bladder muscle and/or serosal invasion in patients with cervical cancer treated with radiotherapy. , 2010, The British journal of radiology.
[154] C. Atkinson,et al. The malignant psoas syndrome revisited: case report, mechanisms, and current therapeutic options. , 2010, Journal of palliative medicine.
[155] T. Oliver,et al. Follow-up for women after treatment for cervical cancer: a systematic review. , 2009, Gynecologic oncology.
[156] W. Aulitzky,et al. Subkutane Drainage zur Behandlung des malignen Lymphödems in der palliativen Situation nach Versagen der komplexen physikalischen Entstauungstherapie , 2009 .
[157] R. Dienstmann,et al. Palliative percutaneous nephrostomy in recurrent cervical cancer: a retrospective analysis of 50 consecutive cases. , 2008, Journal of pain and symptom management.
[158] A. Sood,et al. Malignant mixed mullerian tumor (MMMT) of the cervix. , 2005, Gynecologic oncology.
[159] R. Fisher,et al. Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy , 2004, International Journal of Gynecologic Cancer.
[160] E. Bruera,et al. Palliative Management of Malignant Bowel Obstruction , 2002, International Journal of Gynecologic Cancer.
[161] C. Dykewicz. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[162] P. Clement,et al. Malignant Mullerian Mixed Tumors of the Uterine Cervix: A Report of Nine Cases of a Neoplasm With Morphology Often Different From Its Counterpart in the Corpus , 1998, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[163] S. Leeder,et al. A population based study , 1993, The Medical journal of Australia.
[164] V. Kahanpaa. [Radiotherapy of cervical cancer]. , 1952, Suomen laakarilehti. Finlands lakartidning.
[165] M. Hruda,et al. Individualization of surgical management of cervical cancer stages IA1, IA2. , 2019, Ceska gynekologie.
[166] Shengjie Li,et al. Recent Advances , 2018, Journal of Optimization Theory and Applications.
[167] Dennis Andersson,et al. A retrospective cohort study , 2018 .
[168] M. Stoler,et al. A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix. , 2018, Gynecologic oncology.
[169] A. Judge,et al. A RETROSPECTIVE SINGLE-CENTRE COHORT STUDY , 2017 .
[170] Carcinoma of the Cervix Histopathology Reporting Guide , 2016 .
[171] Si-meng Jiao,et al. The negative conversion of high-risk human papillomavirus and its performance in surveillance of cervical cancer after treatment: a retrospective study , 2016, Archives of Gynecology and Obstetrics.
[172] Naoki Ishiguro,et al. A MULTICENTRE STUDY , 2010 .
[173] M. Benjapibal,et al. Cervical cancer in pregnancy. , 2010 .
[174] M. Jung,et al. Small cell carcinoma of the uterine cervix: clinicopathologic study of 20 cases in a single center. , 2009, European journal of gynaecological oncology.
[175] S. Gabriel,et al. Systematic Review of the Literature , 2021, Adherence to Antiretroviral Therapy among Perinatal Women in Guyana.